News

We recently had the chance to sit down with Seth Green, who began his journey with MetrumRG in January 2020 and has been an essential leader in the Data Science group. Seth has a diverse background spanning machine learning, applied statistics, big data engineering, and data visualization. He  also brings experience in software engineering, having developed tools and platforms for both the digital advertising and scholarly publishing industries. Before diving into data science, Seth spent nearly a decade touring as a professional musician, adding a unique edge to his technical expertise.

We are excited to announce that Dr. Brian Corrigan will join MetrumRG as Principal Consultant, Strategic Advisory Solutions in January, 2025. With a distinguished career spanning nearly three decades in biopharma,  Brian brings unparalleled leadership and expertise to this newly launched offering.

We are pleased to announce Metrum Research Group's new business offering, Strategic Advisory Solutions. With over two decades of excellence in quantitative approaches to drug development, MetrumRG is advancing these strategies to enterprise-level decision making through this newly formed service.

In this edition of our Employee Spotlight, we are excited to introduce you to Sara Miller. Sara joined MetrumRG in 2021 as a science writer. She completed her PharmD at the University of Connecticut, where she co-founded the CPE-accredited practice-based Medical Writing Certificate Program. Before joining MetrumRG, Sara worked as a freelance medical writer, contributing to publications like Pharmacy Times and Contemporary Clinic. Her passion for writing and promoting science drives her work at MetrumRG.

In this month’s Employee Spotlight, we’re excited to feature Thomas Kenney, MetrumRG’s  Administrative Assistant and member of the Talent & Culture Team. Thomas's role is integral to the smooth functioning of our office. He is responsible for various clerical and organizational tasks, assists with monthly expense reporting, and ensures that our office is always stocked with a variety of coffee—a task that he humorously notes might be the most important of all.

What do you like most about working at MetrumRG?

"It's hard to choose what I like most about working here. Before joining the civilized working world, the majority of my experience was in fast-paced and high-stress emergency service jobs. I used to work in dimly lit, windowless rooms from 6:00 PM to 6:00 AM with a group of over-caffeinated EMTs, police officers, firefighters, and dispatchers.

I am excited to share that one of our recent papers written in collaboration with EMD Serono, Pharmacometric modeling and machine learning analyses of prognostic and predictive factors in the JAVELIN Gastric 100 phase III trial of avelumab, has been recognized as one of the most cited in its publication last year. Reflecting on this achievement, I wanted to provide some insights into why I believe this paper resonated so strongly with the pharmacometrics community and became such a valuable resource.

We're excited to shine the spotlight on Kiersten Utsey, a valued member of our team here at MetrumRG. Her primary focus involves utilizing mechanistic modeling and simulation to support decision-making processes throughout various stages of drug development. This entails synthesizing data from diverse sources, including in vitro studies, animal models, and clinical trials, to construct models that describe both the mechanism of action of drugs and the underlying physiology of diseases. Kiersten initially joined MetrumRG as a Quantitative Systems Pharmacology Intern while working on her Ph.D. in Mathematics at the University of Utah. After graduating from the U, Kiersten transitioned into a role as a research associate at MetrumRG. Quickly advancing, she became a research scientist in our Translational Science and Pharmacology (TSP) group. 

Twenty years ago, the Metrum Research Group journey began. Marc Gastonguay and Jeff Hane founded the company in 2004 with a mission to improve health and defeat disease.

I joined Metrum Research Group in the Fall of 2022 as a research scientist in PKPD, driven by a passion for modeling and simulation analyses of clinical trial data. My journey into this field was profoundly shaped by my experiences during a post-doc at a nonprofit organization, where I had the chance to collaborate closely with patient advocacy groups in the rare disease community. Their unwavering determination and resilience have inspired me to continue my work towards finding cures and creating innovative drug development solutions. In honor of Rare Disease Day, I am grateful to have the opportunity to share my journey of fruitful collaboration that has shaped my perspective.

Eric Anderson has been an invaluable member of the MetrumRG team since 2017. Over the years, has contributed a practical and dedicated approach to skillfully navigating the complexities of data.

Eric began his career in the insurance industry as an actuarial analyst. His experience in analyzing insurance data and modeling risk put him in a position to smoothly transition into the field of model-informed drug development at MetrumRG. In his current role, Eric assembles clinical trial data into model-ready datasets, creates visualizations (including interactive dashboards) to help describe data, and develops tools to help facilitate these and other modeling project tasks.